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Background
Myotonic dystrophy type II (MD2) is a genetic multisyste-
mic disorder characterized by skeletal muscle (SM) symp-
toms, metabolic changes as well as arrhythmias1.
Histopathologic changes of the SM may include fibrosis
and fatty degeneration2. The aim of this study is to evaluate
myocardial structure in preserved ejection fraction (EF).
Methods
We prospectively enrolled 32 subjects with a genetically
confirmed diagnosis of MD2. Exclusion criteria were
known cardiac diseases and contraindication for CMR.
We assessed left-ventricular (LV) volumes, mass and func-
tion applying state of the art cine imaging using a 1.5 T
Scanner. Late enhancement imaging (LGE; slice thickness
(sth) 7 mm) was performed to detect myocardial fibrosis
10 minutes after injection of gadoteridol (0.2 mmol/kgbw).
We applied T1 Mapping based on MOLLI (TI native 211
ms, TI post-contrast 281 ms, TE 1.08 ms, sth 6 mm)
before and 15 minutes after contrast application and
assessed resultant extracellular volume fraction (ECV).
Fat-water-separated imaging3 (GRE, TR 944.80 ms, TE
1.53-8.22 ms, sth 6 mm) was performed to identify myo-
cardial fat deposits. Furthermore, we used 1H magnetic
resonance spectroscopy (MRS) (TR 1600 ms, TE 35 ms,
septal voxel 20 x 15 x 6 mm³) to quantify myocardial Tri-
glycerides (MTG). Data were analyzed using cvi42 and
standard line-fitting procedure.
Results
26 data sets were totally completed (age 53.8 ± 11 y,
LVEF 65 ± 0.6 %, 19 women). None of the patients had
wall motion abnormalities. LGE was detectable in 6 of
28 subjects (LGE+; 3 women); the location was mostly
subepicardial inferolateral basal (Figure 1). In case of
LGE+, the T1-values of the enhanced regions were sig-
nificantly different to remote myocardium in both the
native (p = 0.03) and the post-contrast maps (p = 0.03).
ECV and T1 values of the remote myocardium were not
different between LGE+ and LGE negative (LGE-)
groups besides to the inferolateral located ECV (25.6 %
vs. 34.3 %, p = 0.03) (Figure 2). Fat deposits were
noticeable in 6 of 30 subjects (all women, one with LGE
+) in the apical portion of the interventricular septum.
The content of MTG in LGE+ and LGE- subjects was
not significant different (0.34 % vs. 0.74 %, p = 0.47).
Conclusions
Despite preserved LVEF we could detect myocardial injury
in patients with myotonic dystrophy type II. Already native
T1-values were increased in case of subepicardial fibrosis
compared to remote myocardium. To conclude, this is the
first study constituted that CMR is feasible to detect sub-
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Figure 1 Image findings in LGE negative (LGE-, on the left) and positive (LGE+, on the right) patients. On top the LGE images, followed by
native T1 Maps and MRS spectra. Arrows: LGE+; colored voxels (arrowheads): T1 values + 2 standard deviations to the reference myocardium (stars)
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Figure 2 Comparison of LGE negative (LGE-) and LGE positive (LGE+) subjects. The inferolateral extracellular volume fraction (ECV) was
significantly different in these two groups. MTG: Content of myocardial triglycerides measured by magnetic resonance spectroscopy. * The
correlation to LGE+ was significant (p < 0.01)
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